Odyssey, a functional mushroom-infused energy drink brand, has officially concluded a successful $6 million funding round.
The company said the financial milestone signifies a “pivotal moment” in the brand’s development, indicating a growing endorsement of its “distinctive blend of vitality and cognitive enhancement”.
The funding round included Richard Laver from Rocket Beverage Group as an investor, along with continued support from existing stakeholders, contributing 50% of the total raised amount.
Odyssey’s drinks are formulated with adaptogenic ingredients including lions mane and cordyceps mushrooms, designed to deliver an energy boost alongside cognitive clarity, focus and improved mood.
Odyssey plans to allocate the recently acquired capital to support three crucial areas during its rapid growth: sales, marketing and inventory. These investments are expected to expedite the brand’s expansion, making its products more widely accessible.
Scott Frohman, founder and CEO of Odyssey, stated: “Unlike other brands on the market, we’ve formulated Odyssey to support cognitive energy and prioritise aspects like focus, clarity and mood through a proprietary functional mushroom-based formula. Odyssey leverages the high potency extract of Lions Mane, Cordyceps, L-Theanine, Ginseng and green tea caffeine to not only minimise the jitters associated with traditional energy drinks but also deliver sustained, crash-free energy support.”
Odyssey offers three product lines: Odyssey Mushroom Elixir, the original drink; Odyssey 222, a drink with 222mg of caffeine; and Odyssey Revive, which, instead of caffeine and stimulants, uses electrolytes, magnesium, zinc and vitamin C.
Each product line is without added sugar, preservatives, artificial flavours or sweeteners. The brand adheres to vegan, non-GMO and kosher standards. Each flavour includes the brand’s functional mushroom blend. Odyssey’s range is available in selected US retailers.
© FoodBev Media Ltd 2024